Mehdi Hamadani, MD

@MediHumdani

Milwaukee, WI

Joined May 2013

3KFollowing

12KFollowers

Pinned

Mehdi Hamadani, MD@MediHumdani · Apr 23, 2024

The story of my CART pt as painted by her continues. Her latest (bottom right) shows ongoing need for neutrophils 2 years post #CART #lymsm Her prior work in thread below @MCWCancerCenter

MediHumdani's tweet image. The story of my CART pt as painted by her continues. Her latest (bottom right) shows ongoing need for neutrophils 2 years post #CART #lymsm
Her prior work in thread below @MCWCancerCenter

109

8.0K

Pinned

Mehdi Hamadani, MD Retweeted

Lubna Chaudhary MD, MS@LubnaChaudhary1 · Jul 2

What a fun way to raise funds for cancer research! I improvised with the chemo cap and breast cancer ribbon to her chest. #Breastcancer #PinkPedalsPrevail @rideaudaxity @MedicalCollege @Froedtert

906

Pinned

Mehdi Hamadani, MD@MediHumdani · May 14

Hint: Majority is getting the answer wrong #gvhd

MMehdi Hamadani, MD@MediHumdani · May 13

Quiz time: 2year alloBMT survivor on tapering doses of jakafi for GVHD involving eyes, mouth, liver presents with “itchy” rash 👇👇 Skin appears thin and pinch-able. Pick diagnosis in poll below and management in comments #medEd #bmtsm

1.0K

Mehdi Hamadani, MD@MediHumdani · Jul 24

HGBCL-NOS: We identify another histology with relatively CAR resistant relapse. N=111, most axi-cel, 2 year OS and PFS 42% and 29%. NRM 3%. #lymsm #cibmtr BJH | Wiley Online Library onlinelibrary.wiley.com/doi/10.1111/bj…

MediHumdani's tweet card. High-grade B-cell lymphoma not otherwise specified (HGBCL-NOS) is a subtype of aggressive B-cell lymphoma that was only recently classified within the past decade. Although CD19 chimeric antigen...

3.0K

Mehdi Hamadani, MD@MediHumdani · Jul 3

Our deeper dive on @BMTCTN 1506 aka Morpho trial: FLT3-ITD/NPM1 co mutants with residual MRD uniquely benefit from #gilteratinib maintenance. FLT3-ITD/NPM1 co-mutation status may inform #alloHCT conditioning intensity decision #bmtsm #leusm ashpublications.org/bloodadvances/…

4.0K

Mehdi Hamadani, MD@MediHumdani · Jun 13

Has the honor of participating in the inaugural @bmtctn Next Generation Scholar Program meeting #bmtsm

2.0K

Mehdi Hamadani, MD@MediHumdani · Jun 9

Furthering our work for best strategy in established chemosensitive MYC+ LBCL #lymsm CART of autoHCT? #bmtsm @FateehaFurqan et al. onlinelibrary.wiley.com/doi/full/10.10…

4.0K

Mehdi Hamadani, MD@MediHumdani · May 14

Answers below. Option C was correct #morphea like chronic #Gvhd

MMehdi Hamadani, MD@MediHumdani · May 13

Diagnosis?

1.0K

Mehdi Hamadani, MD Retweeted

Mehdi Hamadani, MD@MediHumdani · May 13

Diagnosis?

2.0K

Mehdi Hamadani, MD Retweeted

International Myeloma Foundation@IMFmyeloma · May 10

Congratulations to @szusmani on being recognized by The @OncLive Giants of Cancer Care program. Currently Chief of Myeloma Service at @MSKCancerCenter , Dr. Usmani is also a member of The International Myeloma Foundation's Scientific Advisory Board. onclive.com/view/giants-of…

5.0K

Mehdi Hamadani, MD@MediHumdani · May 12

If done correctly, it will be a highly impactful executive order to reduce astronomically ridiculous drug costs in the U.S.A. #CART #genetherapy #cancermed #targetedagents all unfairly prices in USA

TThe White House@WhiteHouse · May 11

JUST IN: PRESIDENT TRUMP'S "MOST IMPORTANT AND IMPACTFUL" TRUTH EVER ISSUED ⬇️ "I am pleased to announce that Tomorrow morning, in the White House, at 9:00 A.M., I will be signing one of the most consequential Executive Orders in our Country’s history...."

3.0K

Mehdi Hamadani, MD@MediHumdani · May 9

Editing is too funny 😂

BBlood Cancers Today@Blood_Cancers · May 8

Before moderating the aggressive NHL panel discussion at #HOPLive, Dr. @MediHumdani sends the audience into laughter telling the story of his travel fiasco. We’re glad you made it to lead this important talk! Stay tuned for the full-length session➡️ bloodcancerstoday.com/page/the-hemon…

3.0K

Mehdi Hamadani, MD@MediHumdani · May 3

Well that a wrap from @Blood_Cancers #HOPLive in Austin, TX. Thank you, to all colleagues attending and HOP team and @szusmani & @Daver_Leukemia Here to serious BBQ in TX

MediHumdani's tweet image. Well that a wrap from @Blood_Cancers #HOPLive in Austin, TX. Thank you, to all colleagues attending and HOP team and @szusmani &amp; @Daver_Leukemia
Here to serious BBQ in TX

3.0K

Mehdi Hamadani, MD@MediHumdani · May 3

Our superstar @bhemato @Blood_Cancers #HOPLive smoldering #myeloma session #mmsm @szusmani Sham Mailankoy

2.0K

Mehdi Hamadani, MD@MediHumdani · May 3

Day2 @Blood_Cancers #HOPLive session on newly diagnosed MM #mmsm @szusmani @bhemato

1.0K

Mehdi Hamadani, MD@MediHumdani · May 3

Day #2 @Blood_Cancers #HOP controversies in #Hodgkin lymphoma: Phillip Armand @timfenske @NEpperla @UDuraniMD #lymsm

955

Mehdi Hamadani, MD@MediHumdani · May 2

ALL Controversies: outstanding overview at @Blood_Cancers HOP meeting #leusm Nick Short @Daver_Leukemia @sanamloghavi @MDAndersonNews

MediHumdani's tweet image. ALL Controversies: outstanding overview at @Blood_Cancers HOP meeting #leusm Nick Short @Daver_Leukemia @sanamloghavi @MDAndersonNews

2.0K

Mehdi Hamadani, MD@MediHumdani · May 2

Controversies in T-cell NHL: Dr. Zain @Blood_Cancers Day#1

1.0K